Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$7.9M
1 round on record
Latest round
$7.9M
Venture round · Feb 2025 · 19 mo ago
Backers
1
Y Combinator
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Tractionpublic signals, read monthly
Web presence
top 6%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2025 | $7.9M | — | bioworld.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Y Combinator Similar startupsby what they do, their industry and backers
AI agents that run, grow, and self-optimize your mobile app, in every market, every week.
AI writes the code, preview environments ship it. Release gives every pull request and every AI agent a full-stack, production-like…
Turn conversations into revenue with AI Agents on-site, WhatsApp, and voice. Built for modern eCommerce brands.
Run your entire close with AI agents.. Nominal plugs into your existing systems and runs your accounting workflows — so your team can spend…
MOVEdot puts AI agents on the manual load of vehicle development, so testing, simulation, and validation keep pace. Runs in your own cloud.
Humans as a Service for AI Agents. On-demand human experts via the Model Context Protocol.
Overview
Approxima plugs into your CI/CD and runs AI agents on every pull request. They build your app in an isolated sandbox, test it in a real browser, and report exactly what.
News
Approxima raises €7.3M for tricuspid valve regurgitation device
Approxima Srl raised €7.3 million (US$7.65 million) in the first close of its series A financing round for its tricuspid valve repair system which is based on reshaping the right ventricle.
Read more
Report
Enea Tech investe in Approxima su tecnologia in cardiochirurgia - Medicina - Ansa.it
Enea Tech e Biomedical investono in Approxima Srl, startup MedTech innovativa impegnata nello sviluppo di una tecnologia percutanea di rimodellamento del ventricolo destro per il trattamento dell'insufficienza tricuspidale. (ANSA)
Read more
Report
Financials
Total raised
$7.9M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $7.9M | Details |